Header Logo

Connection

Bin Guo to Cell Line, Tumor

This is a "connection" page, showing publications Bin Guo has written about Cell Line, Tumor.
Connection Strength

0.611
  1. A CRISPR-Cas9 repressor for epigenetic silencing of KRAS. Pharmacol Res. 2021 02; 164:105304.
    View in: PubMed
    Score: 0.168
  2. Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells. Int J Mol Sci. 2020 Jun 30; 21(13).
    View in: PubMed
    Score: 0.164
  3. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2. Int J Mol Sci. 2020 Mar 27; 21(7).
    View in: PubMed
    Score: 0.161
  4. A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells. Bioorg Chem. 2021 11; 116:105340.
    View in: PubMed
    Score: 0.045
  5. Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping. J Control Release. 2019 Oct; 311-312:43-49.
    View in: PubMed
    Score: 0.039
  6. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol. 2018 Jan; 13(1):82-89.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.